Stock screener

APGE

Conviction 97HealthcareScan · Thu, Jun 25, 2026
APGE$132.68-0.01%
ResistanceSupportVol 14Insider sell
63 bars
2
6
2
2
3
3
Vol MA14 7.25M
Mar 26Apr 14May 1May 19Jun 8Jun 25
WSB mentions · 24h changelatest +200.00%· 3 mentions
Mar 26Apr 14May 1May 19Jun 8Jun 25
Apogee Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.apogeetherapeutics.com ↗
Price132.68
Change-0.01%
Gap+0.13%
Rel volume1.87×
Avg volume5.43M
Avg $ vol677.03M
SMA 2094.48
SMA 5088.42
SMA 20071.28
Price vs 50+50.06%
Price vs 200+86.15%
MA stackbullish
50/200 cross—
Supertrendup · 113.70
RSI (14)81
MACD hist5.65
MACD cross—
Stoch %K / %D99 / 99
ADX (14)30
+DI / −DI55 / 10
RSI divergence—
MACD divergence—
ATR %+4.55%
ADR %4.64%
52w high132.88
52w low34.65
From 52w high-0.15%
Above 52w low+282.91%
New 52w highYes
SqueezeOff
Bollinger width82.30%
%B0.99
Donchian pos99.15%
Donchian high133.16
Donchian low77.00
AVWAP (52w high)132.79
vs AVWAP high-0.08%
AVWAP (52w low)89.96
vs AVWAP low+47.49%
OBV trendUp
Chaikin MF (20)-0.43
Today vs 20d1.87×
Avg vol (14d)7.25M
Avg vol (20d)5.43M
Avg $ vol (20d)677.03M
Market cap9.94B
RS 3m (vs SPY)+69.51%
RS 6m (vs SPY)+61.21%
RS line new highYes
Trend template8/8
Technical rank94.5
1 week+50.04%
1 month+60.22%
3 months+68.95%
6 months+70.10%
1 year+204.66%
YTD+75.09%
P/E-38.83
P/B—
P/S—
P/FCF-42.72
EPS-4.22
Div yield—
ROE—
ROA-19.78%
Debt/Eq—
Current32.59
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-40.46%
Price target128.81
Target upside-2.92%
Analyst ratingHold
Institutional132.86%
Ent. value9.48B
Revenue—
Net income-74.11M
Gross profit—
Free cash flow-232.6M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out61.9M
Employees261
ListedFri, Jul 14, 2023
Free float55.65M
Float %81.5%
Short interest10.53M
Days to cover9.4d
Short volume25.5%
Squeeze score76 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.06 vs −$1.12
Last surprise+5.4% beat
Setup gradeA+
Conviction97 / 100
Pattern quality—
Tech rank94.5 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance112.53
Support75.43
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in APGE

All disclosures →
No recent disclosed trades by Congress in APGE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in APGE · 10 sells

InsiderSideShares
HENDERSON MICHAEL THOMAS
Chief Executive Officer · Common Stock · 2026-06-22
Sell80K
Dambkowski Carl
Chief Medical Officer · Common Stock · 2026-06-22
Sell26.4K
HENDERSON MICHAEL THOMAS
Chief Executive Officer · Common Stock · 2026-06-10
Sell6.77K
HENDERSON MICHAEL THOMAS
Chief Executive Officer · Common Stock · 2026-06-10
Sell7.65K
HENDERSON MICHAEL THOMAS
Chief Executive Officer · Common Stock · 2026-06-10
Sell1.08K
HENDERSON MICHAEL THOMAS
Chief Executive Officer · Common Stock · 2026-06-10
Sell1.58K
HENDERSON MICHAEL THOMAS
Chief Executive Officer · Common Stock · 2026-06-10
Sell2.31K
HENDERSON MICHAEL THOMAS
Chief Executive Officer · Common Stock · 2026-06-10
Sell614
Dambkowski Carl
Chief Medical Officer · Stock Option (Right to Buy) · 2026-06-03
Exercise4.13K
Dambkowski Carl
Chief Medical Officer · Common Stock · 2026-06-03
Sell5.5K

SEC filings

EDGAR filings in APGE · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.